Clinical Trial

Vanderbilt Memory and Aging Project

Study acronym: VMAP
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study will use an observational cohort to cross-sectionally and longitudinally relate vascular health to clinical, imaging, and biological markers of early Alzheimer's disease and cerebrovascular disease among aging adults. Adjusting for relevant clinical covariates, we will test the hypothesis that vascular health is associated with clinical, brain magnetic resonance imaging (MRI), neuropsychological, and cerebrospinal fluid markers of early cerebrovascular and Alzheimer's disease changes (i.e., prior to the onset of significant cognitive decline or dementia). Secondarily, we will examine medical and genetic factors that might mediate associations between vascular health and brain aging, such as inflammatory processes, insulin resistance, and genetic factors (e.g., APOE, a susceptibility risk factor for dementia). Findings will advance knowledge regarding the role that vascular health plays in brain aging.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-15
notable Primary completion pushed: 2026-12-31 -> 2027-12-31 2026-08-15
minor Completion pushed: 2026-12-31 -> 2027-12-31 2026-08-15
Trial Details
NCT Number NCT05372159
Lead Sponsor Vanderbilt University Medical Center
Collaborators: National Institute on Aging (NIA), National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Alzheimer Disease, Aging, Aged, 80 and Over, Biomarkers, Brain, Case-Control Studies, Cognitive Dysfunction, Neuropsychological Tests
Enrollment 1,000 participants
Start Date 2012-09-17
Primary Completion 2027-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-14